Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
53% of U.S. Tenants Face Housing Affordability Crisis
-
NAPC Defense (OTCPK: BLIS) Awarded in Excess of $1 Million in Clean-up Contracts following Hurricanes Helene and Milton
-
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT plc
-
Wolters Kluwer N.V.: Future Ready Lawyer Survey 2024: Legal professionals confident in managing AI-driven changes to business of law
-
First Merchants Corporation Announces Third Quarter 2024 Earnings per Share
-
Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
-
Carpenter Technology Reports First Quarter Fiscal Year 2025 Results
-
Outbrain to Release Third Quarter 2024 Financial Results on November 7, 2024
-
Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
Dupixent® (dupilumab) Late-Breaking Positive Phase 3 Data in Chronic Spontaneous Urticaria to Be Presented at ACAAI
-
PetMed Express, Inc. Sets Fiscal Second Quarter 2025 Earnings Call
-
Harsco Environmental Secures 10-Year Contract with Nucor Steel Kingman
-
Integer Holdings Corporation Reports Third Quarter 2024 Results
-
Hydrofarm Holdings Group, Inc. to Announce Third Quarter 2024 Results on November 7, 2024
-
Radius Recycling Reports Fourth Quarter and Fiscal 2024 Financial Results
-
Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program
-
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
-
First Watch Restaurant Group, Inc. to Report Third Quarter 2024 Financial Results on November 7, 2024
-
Defined Benefit Pensioners Contribute Billions to Ontario's Economy
-
Payman Khales to assume the role of Integer Chief Operating Officer and Andrew Senn to become President, Cardio & Vascular in the first quarter of 2025
-
BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)
-
DMC Global Schedules Third Quarter Earnings Release and Conference Call
-
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
-
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
-
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances
-
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024
-
Blue Cross and Blue Shield of Minnesota Foundation Awards More Than $4m to 18 Nonprofits
-
Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise
-
Bryn Pharma Appoints Joshua Ziel as Chief Executive Officer
-
LifeVantage to Participate at the LD Micro Main Event XVII
-
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time
-
Hanmi Financial Declares Cash Dividend of $0.25 per share
-
LifeMD® to Report Third Quarter 2024 Financial Results on November 7
-
Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Disea
-
ABM and Mainspring Energy Sign Strategic Partnership
-
Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting
-
NANO Nuclear Energy Announces Pricing of Upsized $36 Million Underwritten Offering
-
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
-
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
-
Arcutis Presents Positive Patient-Reported Outcome Data for ZORYVE® (Roflumilast) Cream 0.15% in Atopic Dermatitis at American College of Allergy, Asthma and Immunology 2024 Annual Scientific Meeting
-
Sonoco To Report Third Quarter 2024 Results
-
ENGIE announces Power Purchase Agreement with Google – Will supply power from its largest U.S. solar project to date
-
Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film
-
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage
-
Skyharbour Announces ANT Survey Prior to Upcoming Drill Program as well as Summary of 2024 Drilling to Date at Russell Lake Uranium Project, Northern Saskatchewan
-
Tri Pointe Homes Named to 2024 Fortune Best Workplaces for Women™ List for the Third Consecutive Year
-
Equipment Leasing and Finance Association CapEx Finance Index: September 2024
-
New Bluebeam Research Reveals Growing AI Use in Construction, but Regulatory and Talent Challenges Persist
-
CareCloud To Announce Third Quarter 2024 Results on November 12, 2024
